Contemporary classification of acute pulmonary embolism (PE) severity is based on the risk
of early death, which is influenced by demographic factors, comorbidity, and the functional …

Thrombolytic therapy leads to a more rapid rate of resolution of pulmonary embolic
obstruction then standard therapy with heparin. This has been documented by angiography …

The original Pulmonary Embolism Severity Index (PESI) is a validated clinical tool to predict
outcomes in patients with acute pulmonary embolism [1–6]. Based on 11 readily available …

only 0.1% to 3.8% of patients with PE, 16, 18 and mechanisms to identify this subset of
patients a priori are not available. It is unfortunate that clinical outcomes were not reported in …

Patients with pulmonary embolism can be divided in two groups according to their risk of
death or major complication: a small group of high‐risk patients defined by the presence of …

The impact of adherence to published guidelines on the outcomes of patients with acute
pulmonary embolism (PE) has not been well defined by previous studies. In this prospective …

Background Therapeutic anticoagulation is the cornerstone of treatment for pulmonary
embolism (PE), but the impact of different anticoagulation strategies on patient outcomes …

Background Clinical guidelines have supported outpatient treatment of low‐risk pulmonary
embolism (PE) since 2014, but adoption of this practice has been slow. Direct oral …

Pulmonary embolism (PE) is a serious and costly disease for patients and healthcare
systems. Guidelines emphasise the importance of differentiating between patients who are …

Venous thromboembolism is a frequently occurring and potentially fatal disease
characterized by short-term and long-term sequelae. Conventional treatment consists of …